Platelet APP isoform ratios correlate with declining cognition in AD - PubMed (original) (raw)
. 2000 May 23;54(10):1907-9.
doi: 10.1212/wnl.54.10.1907.
Affiliations
- PMID: 10822427
- DOI: 10.1212/wnl.54.10.1907
Platelet APP isoform ratios correlate with declining cognition in AD
F Baskin et al. Neurology. 2000.
Abstract
Background: Platelets and neurons both contain large quantities of two carboxyl-truncated 120 to 130 and 110 kDa Alzheimer amyloid precursor proteins (APPs). Platelets taken from patients with AD have been reported to contain a reduced ratio of these APPs.
Objective: To further study the AD specificity of reduced platelet APP ratios and to determine whether, after 3 years, cognitive losses in AD are accompanied by similarly reduced platelet APP ratios.
Methods: To test the AD specificity of reduced platelet APP ratios, we quantitated these APPs in eight patients with PD and six patients with hemorrhagic stroke (HS). To determine whether further cognitive losses correlate with platelet APP ratio reductions in patients with AD, the authors re-examined platelet APPs and Mini-Mental State Examination (MMSE) scores of 10 patients with AD and 11 controls, who were tested 3 years ago. APP ratios were determined by the average of six assays using Western blotting with m22C11 monoclonal antibody, enhanced chemoluminescence, and digital scanning of autoradiographs.
Results: APP ratios were normal in the patients with PD and HS, further supporting the AD specificity of this assay. After 3 years, the MMSE scores and APP ratios of our control subjects changed by <4%. However, the average MMSE scores of our patients with AD declined from 16.4 to 8.3, and their average 120 to 130/110 kDa APP ratios declined from 5.8 to 3.6. The difference between AD and control APP ratios, with no overlap, is significant and the correlation between the 3-year decline in AD MMSE scores and reduced APP ratios (r = 0.69) was significant.
Conclusions: Although the number of subjects analyzed was limited, reduced platelet APP ratios appear to be a specific biological marker of AD and a biological index of the severity of cognitive loss in AD.
Similar articles
- Correlation between platelet amyloid precursor protein isoform ratio and cognition in Alzheimer's disease.
Liu HC, Wang HC, Ko SY, Wang PN, Chi CW, Hong CJ, Lin KN, Liu TY. Liu HC, et al. J Alzheimers Dis. 2007 Mar;11(1):77-84. doi: 10.3233/jad-2007-11111. J Alzheimers Dis. 2007. PMID: 17361037 - Platelet APP isoform ratios in asymptomatic young adults expressing an AD-related presenilin-1 mutation.
Baskin F, Rosenberg RN, Iyer L, Schellenberg GD, Hynan L, Nee LE. Baskin F, et al. J Neurol Sci. 2001 Jan 15;183(1):85-8. doi: 10.1016/s0022-510x(00)00483-4. J Neurol Sci. 2001. PMID: 11166800 - The platelet amyloid precursor protein ratio as a diagnostic marker for Alzheimer's disease in Thai patients.
Srisawat C, Junnu S, Peerapittayamongkol C, Futrakul A, Soi-ampornkul R, Senanarong V, Praditsuwan R, Assantachai P, Neungton N. Srisawat C, et al. J Clin Neurosci. 2013 May;20(5):644-8. doi: 10.1016/j.jocn.2012.06.008. Epub 2013 Feb 27. J Clin Neurosci. 2013. PMID: 23453155 - Platelet amyloid precursor protein forms in AD: a peripheral diagnostic tool and a pharmacological target.
Padovani A, Borroni B, Colciaghi F, Pastorino L, Archetti S, Cottini E, Caimi L, Cattabeni F, Di Luca M. Padovani A, et al. Mech Ageing Dev. 2001 Nov;122(16):1997-2004. doi: 10.1016/s0047-6374(01)00315-3. Mech Ageing Dev. 2001. PMID: 11589917 Review. - Platelets as a peripheral district where to study pathogenetic mechanisms of alzheimer disease: the case of amyloid precursor protein.
Di Luca M, Colciaghi F, Pastorino L, Borroni B, Padovani A, Cattabeni F. Di Luca M, et al. Eur J Pharmacol. 2000 Sep 29;405(1-3):277-83. doi: 10.1016/s0014-2999(00)00559-8. Eur J Pharmacol. 2000. PMID: 11033334 Review.
Cited by
- Effect of a Cognitive Training Program on the Platelet APP Ratio in Patients with Alzheimer's Disease.
Casoli T, Giuli C, Balietti M, Fabbietti P, Conti F. Casoli T, et al. Int J Mol Sci. 2020 Jul 20;21(14):5110. doi: 10.3390/ijms21145110. Int J Mol Sci. 2020. PMID: 32698329 Free PMC article. - Potential fluid biomarkers for pathological brain changes in Alzheimer's disease: Implication for the screening of cognitive frailty.
Ruan Q, D'Onofrio G, Sancarlo D, Greco A, Yu Z. Ruan Q, et al. Mol Med Rep. 2016 Oct;14(4):3184-98. doi: 10.3892/mmr.2016.5618. Epub 2016 Aug 9. Mol Med Rep. 2016. PMID: 27511317 Free PMC article. Review. - Platelet amyloid precursor protein processing: a bio-marker for Alzheimer's disease.
Tang K, Hynan LS, Baskin F, Rosenberg RN. Tang K, et al. J Neurol Sci. 2006 Jan 15;240(1-2):53-8. doi: 10.1016/j.jns.2005.09.002. Epub 2005 Oct 26. J Neurol Sci. 2006. PMID: 16256140 Free PMC article. - Peripheral Blood Brain-Derived Neurotrophic Factor as a Biomarker of Alzheimer's Disease: Are There Methodological Biases?
Balietti M, Giuli C, Conti F. Balietti M, et al. Mol Neurobiol. 2018 Aug;55(8):6661-6672. doi: 10.1007/s12035-017-0866-y. Epub 2018 Jan 13. Mol Neurobiol. 2018. PMID: 29330839 Free PMC article. Review. - Beyond Haemostasis and Thrombosis: Platelets in Depression and Its Co-Morbidities.
Izzi B, Tirozzi A, Cerletti C, Donati MB, de Gaetano G, Hoylaerts MF, Iacoviello L, Gialluisi A. Izzi B, et al. Int J Mol Sci. 2020 Nov 21;21(22):8817. doi: 10.3390/ijms21228817. Int J Mol Sci. 2020. PMID: 33233416 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical